1. Home
  2. ACOG vs SKYX Comparison

ACOG vs SKYX Comparison

Compare ACOG & SKYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • SKYX
  • Stock Information
  • Founded
  • ACOG 2000
  • SKYX 2004
  • Country
  • ACOG Canada
  • SKYX United States
  • Employees
  • ACOG N/A
  • SKYX N/A
  • Industry
  • ACOG
  • SKYX Building Products
  • Sector
  • ACOG
  • SKYX Consumer Discretionary
  • Exchange
  • ACOG Nasdaq
  • SKYX Nasdaq
  • Market Cap
  • ACOG 149.0M
  • SKYX 139.3M
  • IPO Year
  • ACOG N/A
  • SKYX 2022
  • Fundamental
  • Price
  • ACOG $6.50
  • SKYX $1.70
  • Analyst Decision
  • ACOG Strong Buy
  • SKYX Strong Buy
  • Analyst Count
  • ACOG 1
  • SKYX 1
  • Target Price
  • ACOG $18.00
  • SKYX $5.00
  • AVG Volume (30 Days)
  • ACOG 90.6K
  • SKYX 890.0K
  • Earning Date
  • ACOG 11-14-2025
  • SKYX 11-10-2025
  • Dividend Yield
  • ACOG N/A
  • SKYX N/A
  • EPS Growth
  • ACOG N/A
  • SKYX N/A
  • EPS
  • ACOG N/A
  • SKYX N/A
  • Revenue
  • ACOG $4,586,341.00
  • SKYX $89,028,500.00
  • Revenue This Year
  • ACOG N/A
  • SKYX $8.81
  • Revenue Next Year
  • ACOG $101.16
  • SKYX $28.17
  • P/E Ratio
  • ACOG N/A
  • SKYX N/A
  • Revenue Growth
  • ACOG N/A
  • SKYX 5.71
  • 52 Week Low
  • ACOG $3.75
  • SKYX $0.88
  • 52 Week High
  • ACOG $11.54
  • SKYX $2.14
  • Technical
  • Relative Strength Index (RSI)
  • ACOG 35.21
  • SKYX 63.32
  • Support Level
  • ACOG $6.55
  • SKYX $1.52
  • Resistance Level
  • ACOG $6.95
  • SKYX $1.88
  • Average True Range (ATR)
  • ACOG 0.41
  • SKYX 0.15
  • MACD
  • ACOG -0.00
  • SKYX 0.04
  • Stochastic Oscillator
  • ACOG 0.00
  • SKYX 75.40

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About SKYX SKYX Platforms Corp.

SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.

Share on Social Networks: